HYPOXIC REGULATION OF THE EXPRESSION OF ANTI-ANGIOGENIC GENES IN U87 GLIOMA CELLS WITH ERN1 SIGNALING ENZYME LOSS OF FUNCTION
DOI: http://dx.doi.org/10.30970/sbi.0603.235
Abstract
The angiogenesis is an important component of tumor growth and tightly associated with hypoxia. The expression level of genes related to regulation of angiogenesis (BAI2, SPARC, TIMP1, TIMP2, TIMP3, TIMP4, THBS1, THBS2, ADAMTS5 and FGF2) in glioma U87cells and cells with suppressed function of signaling enzyme ERN1, a major mediator of the endoplasmic reticulum stress by qPCR, was studied. We have shown that the expression of genes encoding BAI2, SPARC, TIMP2, TIMP3, THBS1 and THBS2 is strongly increased in glioma cells with ERN1 signaling enzyme loss of function, being more intense for TIMP2, TIMP3 and THBS1 genes. At the same time, the expression of genes encoding TIMP1, TIMP4, ADAMTS5 and FGF2 is significantly decreased with more strong effect for ADAMTS5 and TIMP4 genes. At hypoxia, the expression of most of studied genes in both glioma cell types is affected. Hypoxia induced the expression of TIMP1, TIMP3 and ADAMTS5 genes both in control glioma cells and cells with ERN1 enzyme loss of function. However, the effect of hypoxia towards TIMP2 gene expression was observed only in control glioma cells. At the same time, the expression of genes encoding BAI2, SPARC, THBS1, THBS2, ADAMTS5 and FGF2 is decreased under hypoxia action, but its expression mostly depended on ERN1 signaling enzyme function. The results of this study provide strong evidence that suppression of ERN1 signaling enzyme function, as well as hypoxia, changes the expression of genes related to regulation of angiogenesis in glioma cells. It is possible that changes in the expression of these genes contribute to the suppression of glioma cells’ proliferation by blockade of ERN1 signaling enzyme functioning.
Keywords
Full Text:
PDFReferences
1. Moenner M., Pluquet O., Bouchecareilh M., Chevet E. Integrated endoplasmic reticulum stress responses in cancer. Cancer Research, 2007; 67(22): 10631-10634. | |
| |
2. Zhang K., Kaufman R.J. Signaling the unfolded protein response from the endoplasmic reticulum. The Journal of Biological Chemistry, 2004; 279(25): 25935-25938. | |
| |
3. Bi M., Naczki C., Koritzinsky M. et al. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. The EMBO Journal, 2005; 24(19): 3470-3481. | |
| |
4. Fels D.R., Koumenis C. The PERK/eIF2- a/ATF4 module of the UPR in hypoxia resistance and tumor growth. Cancer Biology and Therapy, 2006; 5(7): 723-728. | |
| |
5. Romero-Ramirez L., Cao H., Nelson D. et al. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Research, 2004; 64(17): 5943-5947. | |
| |
6. Hollien J., Lin J.H., Li H. et al. Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. The Journal of Cell Biology, 2009; 186(3): 323-331. | |
| |
7. Aragón T., van Anken E., Pincus D. et al. Messenger RNA targeting to endoplasmic reticulum stress signalling sites. Nature, 2009; 457(7230): 736-740. | |
| |
8. Hetz C., Glimcher L.H. Fine-tuning of the unfolded protein response: Assembling the IRE1alpha interactome. Molecular Cell, 2009; 35(): 551-561. | |
| |
9. Korennykh A.V., Egea P.F., Korostelev A.A. et al. The unfolded protein response signals through high-order assembly of Ire1. Nature, 2009; 457(): 687- 693. | |
| |
10. Acosta-Alvear D., Zhou Y., Blais A. et al. XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Molecular Cell, 2007; 27: 53-66. | |
| |
11. Lee J., Sun C., Zhou Y. et al. p38 MAPK-mediated regulation of Xbp1s is crucial for glucose homeostasis. Nature Medicine, 2011; 17(10): 1251-1260. | |
| |
12. Zhou Y., Lee J., Reno C.M. et al. Regulation of glucose homeostasis through a XBP-1-FoxO1 interaction. Nature Medicine, 2011; 17(3): 356-365. | |
| |
13. Park S.W., Zhou Y., Lee J. et al. The regulatory subunits of PI3K, p85alpha and p85beta, interact with XBP-1 and increase its nuclear translocation. Nature Medicine, 2010; 16(4): 429-437. | |
| |
14. Drogat B., Auguste P., Nguyen D.T. et al. IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-A expression and contributes to angiogenesis and tumor growth in vivo. Cancer Research, 2007; 67(14): 6700-6707. | |
| |
15. Auf G., Jabouille A., Guérit S. et al. A shift from an an-giogenic to invasive phenotype induced in malignant glioma by inhibition of the unfolded protein response sen-sor IRE1. The Proceeding of the National Academy of Sciences of the United States of America, 2010; 107(35): 1555-1558. | |
| |
16. Neill T., Painter H., Buraschi S. et al. Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1alpha, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. The Journal of Biological Chemistry, 2012; 287(8), 5492-5506. | |
| |
17. Takahashi K., Mernaugh R.L., Friedman D.B. et al. Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase. The Proceeding of the National Academy of Sciences of the United States of America, 2012; 109(6), 1985-1990. | |
| |
18. John A.S., Hu X., Rothman V.L., Tuszynski G.P. Thrombospondin-1 (TSP-1) up-regulates tissue inhibitor of metalloproteinase-1 (TIMP-1) production in human tumor cells: exploring the functional significance in tumor cell invasion. Experimental and Molecular Pathology, 2009; 87(3):184-188. | |
| |
19. Seo D.W., Saxinger W.C., Guedez L. et al. An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activity in vivo. Peptides, 2011; 32(9): 1840-1848. | |
| |
20. Stetler-Stevenson W.G. Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Science Signaling, 2008; 1: re6. | |
| |
21. Dews M., Homayouni A., Yu D. et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nature Genetics, 2006; 38(9): 1060-1065. | |
| |
22. Hashimoto G., Inoki I., Fujii Y. et al. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. The Journal of Biological Chemistry, 2002; 277(39): 36288-36295. | |
| |
23. Kee H.J., Koh J.T., Kim M.Y. et al. Expression of brain-specific angiogenesis inhibitor 2 (BAI2) in normal and ischemic brain: involvement of BAI2 in the ischemia-induced brain angiogenesis. Journal of Cerebral Blood Flow and Metabolism, 2002; 22(9): 1054-1067. | |
| |
24. Rivera L.B., Bradshaw A.D., Brekken R.A. The regulatory function of SPARC in vascular biology. Cellular and Molecular Life Sciences, 2011; 68(19): 3165-3173. | |
| |
25. Minchenko D.О., Kubajchuk К.І., Hubenia О.V. et al. The effect of hypoxia and ischemic condition on the expression of VEGF genes in glioma U87 cells is dependent from ERN1 knockdown. Advances in Biological Chemistry, 2011; 2(2): 198-206. | |
Refbacks
- There are currently no refbacks.
Copyright (c) 2012 Studia biologica
This work is licensed under a Creative Commons Attribution 4.0 International License.